Preparation and Biological Evaluation of 99mTc-TMPP as a novel Agent for Tumor Diagnosis
- Labeled Compound Department, Hot Lab. Center, Atomic Energy Authority, P.O. Box 13795 Cairo-Egypt.
- Medicinal Chemistry, Faculty of Pharmacy- Zagazig University.
- Abstract
- Keywords
- Cite This Article as
- Corresponding Author
5, 10, 15, 20 tetrakis {4-methoxyphenyl} 21H, 23H porphyrin (TMPP) was labeled with technetium-99m via direct labeling technique using stannous chloride as a reducing agent. The optimum conditions that gave high labeling yield (95.2%) of 99mTc-TMPP complex were achieved by using 3mg TMPP, 100?g SnCl2.2H2O, at pH 3 and 30min reaction time. Molecular geometry was used to illustrate the interaction between 99mTc and TMPP. The preclinical evaluation and biodistribution in solid tumor bearing mice showed high biological accumulation in solid tumor cells (22.66 % injected activity/ g tissue) and high T/NT ratio equal to 3.21 ± 0.15 at 30 minutes post-injection. Data described before could recommend 99mTc-TMPP as a potential targeting radiopharmaceutical for tumor imaging.
[M.F. El-Sabagh, M.A. Motaleb, M.T. El-Kolaly, L.M. Abdel-Aziz and E.M. Lashine (2015); Preparation and Biological Evaluation of 99mTc-TMPP as a novel Agent for Tumor Diagnosis Int. J. of Adv. Res. 3 (Oct). 362-370] (ISSN 2320-5407). www.journalijar.com
